Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Panion & BF Biotech Inc

1760:TAI

Panion & BF Biotech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)86.40
  • Today's Change0.90 / 1.05%
  • Shares traded92.83k
  • 1 Year change-24.21%
  • Beta--
Data delayed at least 20 minutes, as of Nov 01 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.

  • Revenue in TWD (TTM)2.01bn
  • Net income in TWD101.27m
  • Incorporated1976
  • Employees321.00
  • Location
    Panion & BF Biotech Inc16F, Building FNo. 3, Yuanqu Street, Nangang DistrictTAIPEI 115TaiwanTWN
  • Phone+886 226558218
  • Fax+886 226558318
  • Websitehttps://www.pbf.com.tw/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nang Kuang Pharmaceutical Co Ltd2.09bn110.65m4.35bn552.0039.341.9114.852.081.091.0920.7222.520.5711.898.07--3.026.754.479.6433.1434.775.2812.220.631214.420.158782.7410.816.92-43.6314.4119.5110.76
Sinphar Pharmaceutical Co Ltd3.01bn361.33m5.58bn984.0014.321.659.481.852.152.1517.9318.610.48642.286.06--5.71-0.01477.67-0.020339.0237.4911.74-0.03441.4437.220.359979.703.725.9867.01111.883.3158.49
Cenra Inc8.87bn355.20m5.74bn1.40k32.331.558.190.64681.191.1929.7324.900.70272.225.63--2.833.694.034.9636.7936.564.025.500.7959--0.294352.771.402.50-32.51-2.723.57-8.97
Formosa Pharmaceuticals Inc133.70m-298.43m6.42bn----5.64--47.99-2.22-2.220.99637.540.0803--1.61---17.91-40.34-19.62-44.2186.96---223.16-2,488.28----0.0277--2,270.49--20.75---42.98--
Panion & BF Biotech Inc2.01bn101.27m7.33bn321.0072.433.9626.883.651.181.1823.4221.620.61851.739.66--3.124.084.825.6352.6652.375.045.930.869910.620.287111.06-21.545.96-57.65-13.4735.39-3.23
Adimmune Corp1.66bn-607.92m10.42bn564.00--2.03--6.29-1.44-1.443.9311.920.18481.254.04---8.270.6867-10.190.773927.8230.11-44.753.041.99-24.750.328432.80-20.7216.77-319.91--38.05--
SCI Pharmtech Inc1.25bn138.47m10.71bn241.0079.052.1232.418.551.131.1312.7042.260.20441.613.83--2.266.902.548.2627.7538.1811.0619.851.78802.610.182642.3833.83-9.10-4.55-8.0044.67-16.35
Formosa Laboratories Inc4.69bn255.94m10.82bn480.0042.621.4418.032.312.112.1138.9062.490.34791.494.42--0.70672.680.96893.6144.3035.402.038.751.180.89220.315527.3815.8010.16-69.16-6.52-11.6032.22
Data as of Nov 01 2024. Currency figures normalised to Panion & BF Biotech Inc's reporting currency: Taiwan Dollar TWD

Institutional shareholders

4.46%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 02 Oct 20242.62m3.05%
Dimensional Fund Advisors LPas of 03 Oct 2024910.68k1.06%
Mellon Investments Corp.as of 03 Oct 2024113.00k0.13%
Vanguard Fiduciary Trust Co.as of 31 Aug 202462.57k0.07%
SSgA Funds Management, Inc.as of 03 Oct 202453.79k0.06%
DFA Australia Ltd.as of 30 Sep 202424.76k0.03%
Parametric Portfolio Associates LLCas of 31 Aug 202419.00k0.02%
Dimensional Fund Advisors Ltd.as of 31 Aug 202416.88k0.02%
Vanguard Global Advisers LLCas of 30 Sep 20246.21k0.01%
Irish Life Investment Managers Ltd.as of 03 Oct 20242.00k0.00%
More ▼
Data from 30 Jun 2024 - 24 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.